Mechanisms underlying the inhibitory effects of lipopolysaccharide on human platelet adhesion

Platelets

Volumn 21, Issue 4, 2010, Pages 260-269

  Morganti, Rafael P ^a   Cardoso, Marcia H M ^a   Pereira, Fernanda G ^a   Lorand Metze, Irene ^a   De Nucci, Gilberto ^a   Marcondes, Sisi ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Calcium mobilization; Fibrinogen; Platelet adhesion; Reactive oxygen species

Indexed keywords

ACID PHOSPHATASE; AMIDE; CALCIUM; CATALASE; CATALASE POLYETHYLENE GLYCOL; CYCLIC GMP; CYCLOHEXAMIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR; FURA 2; LIPOPOLYSACCHARIDE; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAC 1; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE MACROGOL; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CELL STIMULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTITER PLATE ASSAY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROFLUOROMETRY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ACID PHOSPHATASE; ANIMALS; BLOOD PLATELETS; CALCIUM; CATALASE; CELLS, CULTURED; CYCLIC GMP; CYCLOHEXIMIDE; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN; HUMANS; LIPOPOLYSACCHARIDES; MICE; PLATELET ADHESIVENESS; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN SYNTHESIS INHIBITORS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 77952021223     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537101003637240     Document Type: Article

References (44)

1. Pernerstorfer T, Stohlawetz P, Hollenstein U, Dzirlo L, Eichler HG, Kapiotis S, Jilma B, Speiser W. Endotoxin-induced activation of the coagulation cascade in humans: Effect of acetylsalicylic acid and acetaminophen. Arterioscler Thromb Vasc Biol 1999;19:2517-2523.
2. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689-10692.
3. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K, Kawashima S, Yokoyama M. Expression of Toll-like receptors on human platelets. Thromb Res 2004;113:379-385.
4. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 2005;83:196-198.
5. Andonegui G, Kerfoot SM, McNagny K, Ebbert KVJ, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4. Blood 2005;106:2417-2423.
6. Aslam R, Speck ER, Kim M, Crow AR, Bang KWA, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factorproduction in vivo. Blood 2006;107:637-641.
7. Semple JW, Aslam R, Kim M, Speck ER, Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood 2007;109:4803-4805.
8. Cognasse F, Cognasse HH, Lafarge S, Delezay O, Pozzetto B, McNicol A, Garraud O. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelet. Intensive Care Med 2007;33:382-384.
9. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009;182:7997-8004.
10. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002;30:S313-317.
11. Saba HI, Saba SR, Morelli G, Hartmann RC. Endotoxin-mediated inhibition of human platelet aggregation. Thromb Res 1984;34:19-33.
12. Cicala C, Santacroce C, Itoh H, Douglas GJ, Page CP. A study on rat platelet responsiveness following intravenous endotoxin administration. Life Sci 1997;60:PL31-38.
13. Sheu JR, Hung WC, Kan YC, Lee YM, Yen MH. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. Br J Haematol 1998;103:29-38.
14. Saluk-Juszczak, Wachowics B, Wieslaw K. Stimulatory effects of endotoxin on the platelet secretory process. Microbios 1999;99:45-53.
15. Saluk-Juszczak, Wachowics B, Zielinski T, Wieslaw K. Adhesion of thrombinstimulated and unstimulated blood platelets to collagen in the presence of proteus mirabilis lipopolysaccharides. Platelets 2001;12:470-475.
16. Zielinski T, Wachowicz B, Saluk-Juszczak J, Kaca W. The generation of superoxide anion in blood platelets in response to different forms of Proteus mirabilis lipopolysaccharide: Effects of staurosporin, wortmannin, and indomethacin. Thromb Res 2001;103:149-155.
17. Whitworth NH, Barradas MA, Mikhailidis DP, Dandona P. An investigation into the effects of bacterial lipopolysaccharide on human platelets. Eur J Haematol 1989;43:112-119.
18. Nystrom ML, Barradas MA, Jeremy JY, Mikhailidis DP. Platelet shape change in whole blood: Differential effects of endotoxin. Thromb Haemost 1994;71:646-650.
19. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I. Agonists of toll-like receptor (TLR) 2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 2005;94:831-838.
20. Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest 2006;86:9-22.
21. Ni H, Freedman J. Platelets in hemostasis and thrombosis: role of integrins and their ligands. Trans Apher Sci 2003;28:257-264.
22. Zielinski T, Wachowicz B, Saluk-Juszczak J, Kaca W. Polysaccharide part of Proteus mirabilis lipopolysaccharide may be responsible for the stimulation of platelet adhesion to collagen. Platelets 2002;13:419-424.
23. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994;216:444-450.
24. Marcondes S, Cardoso MHM, Morganti RP, Thomazzi SM, Lilla S, Murad F, De Nucci G, Antunes E. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: A role for α-actinin nitration. Proc Natl Acad Sci USA 2006;103:3434-3439.
25. Donato JL, Marcondes S, Antunes E, Nogueira MD, Nader HB, Dietrich CP, Rendu F, De Nucci G. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation. Br J Pharmacol 1996;119:1447-1453.
26. +2 stores: Studies using Fura 2. Biochem Biophys Res Comm 1986;139:308-314.
27. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G. 2, 7-Dihydrodichlorofluorescein as a fluorescent marker for peroxynitrite formation. FEBS 1997;416:175-178.
28. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003;101:2285-2293.
29. Rosenwald IB, Pechet L, Han A, Lu L, Pihan G, Woda B, Chen JJ, Szymanski I. Expression of translation initiation factors elF-4E and elF-2a and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost 2001;85:142-151.
30. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiov Pharmacol 1996;27:154-158.
31. Gambaryan S, Kobsar A, Hartmann S, Birschmann I, Kuhlencordt PJ, Müller-Esterl W, Lohmann SM, Walter U. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 2008;6:1376-1384.
32. Kleinert H, Schwarz PM, Förstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003;384:1343-1364. (Pubitemid 37508640)
33. Sheu JR, Hung WC, Su CH, Lin CH, Lee LW, Lee YM, Yen MH. The antiplatelet activity of Escherichia coli lipopolysaccharide is mediated through a nitric oxide/cyclic GMP pathway. Eur J Haematol 1999;62:317-326.
34. Cerwinka WH, Cooper D, Krieglstein CF, Ross CR, McCord JM, Granger DN. Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 2003;284:H535-541.
35. Nassem KM, Chirico S, Mohammadi B, Bruckdorfer KR. The symergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation. Biochem J 1996;318:759-766.
36. Dong HP, Chen HW, Hsu C, Chiu HY, Lin LC, Yang RC. Previous heat shock treatment attenuates lipopolysaccharideinduced hyporesponsiveness of platelets in rats. Shock 2005;24:239-244.
37. 2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochem Biophys Res Comm 2005;333:794-802.
38. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004;104:1606-1615.
39. Barret NE, Holbrook L, Jonesi S, Kaiser WJ, Moraes LA, Rana R, Sage T, Stanley RG, Tucker KL, Wright B, Gibbins JM. Future innovations in anti-platelet therapies. Br J Pharmacol 2008;154:918-939.
40. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function throught adhesion receptors: a dual role for glycoprotein Iib-IIIa (integrin αIIbB3) mediated by fibrinogen and glycoprotein Ib-VON Willebrand factor. J Biol Chem 1992;267:11300-11306.
41. Levy-Toledano S. Platelet signal transduction pathways: could we organize them into a "hierarchy"? Haemostasis 1999;29:4-15.
42. De Cristofaro R, De Candia E. Thrombin domains: structure, function and interaction with platelet receptors. J Thromb Thrombolysis 2003;15:151-163.
43. Brass LF. Thrombin and platelet activation. Chest 2003;124:18-25.
44. 2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells. J Physiol 2008;586:427-439.